T44.2X3

Clinical Causes: Accidental ingestion of ganglionic blocking medications Intentional overdose or misuse of these drugs Exposure during assaults or assaults involving toxic substances Mislabeling or accidental administration in healthcare settings Use of these drugs as part of malicious attacks

Key Symptoms: Severe low blood pressure (hypotension) Dizziness or lightheadedness, especially when standing up Blurry vision Dry mouth and dry eyes Constipation and urinary retention Difficulty breathing or respiratory distress Altered mental state, including confusion or agitation Weakness or fatigue Possible loss of consciousness in severe cases Slow or irregular heartbeats

Diagnosis Path: Diagnosis involves a thorough clinical assessment, focusing on recent exposure history and symptom presentation. Laboratory tests may include blood and urine analyses to detect the presence of ganglionic blocking agents. Healthcare providers may also perform electrocardiograms (ECGs) to evaluate heart rhythm abnormalities. Differential diagnosis considers other causes of hypotension and autonomic dysfunction to ensure accurate identification of poisoning.

Treatment Protocols: Management of poisoning by ganglionic blocking drugs often requires immediate medical attention. Supportive care measures may include administering intravenous fluids to stabilize blood pressure and oxygen therapy if breathing is compromised. Activated charcoal might be used to limit drug absorption if ingestion was recent. In some cases, medications that counteract the effects or specialized interventions like vasopressors to increase blood pressure may be necessary. Continuous monitoring of vital signs and cardiac function is essential during treatment. In cases of assault or intentional poisoning, mental health support and legal actions may be part of comprehensive care.